Researchers have demonstrated that activation of the Nrf2/HO-1 pathway assumes a critical role in the management of numerous diseases, including Parkinson’s disease, intracerebral hemorrhage (ICH), osteoarthritis, and others [64,65,66]. Here, NFE2L2 is linked to osteoarthritis.